中文 | English
Return
Total: 32 , 1/4
Show Home Prev Next End page: GO
Author:( Xingwu WANG)

1.Hypoxia-induced caveolin-1 up-regulation is involved in migration and in-vasion of lung adenocarcinoma A549 cells

Bei ZUO ; Min XING ; Zhengui SUN ; Xianghai WANG ; Xingwu CHEN

Chinese Journal of Pathophysiology 2014;(10):1794-1799

2.Effect of S-1 on serum TK1, VEGF, IGF-1 and tumor biomarkers, estrgen levels in patients with advanced breast cancer

Jianlin ZHOU ; Wufang ZHANG ; Wusen YANG ; Xingwu WANG ; Fen LI

Chinese Journal of Biochemical Pharmaceutics 2015;(8):69-71

3.A study on the measuremet of DKK-1 in the serum of esophageal cancer patients

Bobo LI ; Daotang LI ; Dongbo ZHAO ; Xingwu WANG

Journal of International Oncology 2009;36(7):544-547

4.Anti-cancer effect of cytotoxic T lymphocytes activated by sensitized dendritic cells

Xianrang SONG ; Ling WEI ; Xingwu WANG ; Xingkui XUE ; Lihua SONG

Chinese Journal of Pathophysiology 2000;0(11):-

5.Inhibitory effect of arsenic trioxide on human glioma cell growth

Ling WEI ; Xingwu WANG ; Xianrang SONG ; Wenshu ZUO ; Min LI

Chinese Journal of Pathophysiology 1986;0(04):-

7.ERCC1-shRNA inhibits the proliferation and promotes the apoptosis of lung cancer A549/DDP cells

Yifeng JIN ; Cuicui CHAN ; Lei FANG ; Ying WANG ; Xingwu CHEN

Journal of Medical Postgraduates 2017;30(6):591-595

8.Chemotherapy sensitivity and associated gene expression in human breast cancer cells

Ling WEI ; Xianrang SONG ; Xingwu WANG ; Yonglei LIU

Basic & Clinical Medicine 2006;0(08):-

9.The relation between nm23-H_1 protein expression or DNA ploidy and lymph node metastasis of esophageal squamous cell carcinoma.

Xingwu WANG ; Qian GU ; Ling WEI ; Al ET

China Oncology 2001;0(02):-

10.Expression of COX-2 and its significance in rectal familial adenomatous polyposis and rectal cancer tissues

Xianglu LIAO ; Xingwu WANG ; Qian GUO ; Al ET

China Oncology 2001;0(03):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 32 , 1/4 Show Home Prev Next End page: GO